Alberto J. Rico

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Tier-specific location of Lewy body pathology and related neuromelanin levels drive dopaminergic cell vulnerability in pigmented non-human primates.

Tier-specific location of Lewy body pathology and related neuromelanin levels drive dopaminergic cell vulnerability in pigmented non-human primates.

Journal: Neurobiology of disease

Published: May 03, 2026

Biodistribution of AAV-TT and AAV9 in the Nonhuman Primate Brain.

Biodistribution of AAV-TT and AAV9 in the Nonhuman Primate Brain.

Journal: Human gene therapy

Published: March 09, 2026

Introducing PIGMO, a novel PIGmented MOuse model of Parkinson's disease.

Introducing PIGMO, a novel PIGmented MOuse model of Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: September 22, 2025

Quantum Advantage in Identifying the Parity of Permutations with Certainty.

Quantum Advantage in Identifying the Parity of Permutations with Certainty.

Journal: Physical review letters

Published: August 04, 2025

Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles.

Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles.

Journal: Gene therapy

Published: May 16, 2024

Development and characterization of a non-human primate model of disseminated synucleinopathy.

Development and characterization of a non-human primate model of disseminated synucleinopathy.

Journal: Frontiers in neuroanatomy

Published: December 14, 2023

Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease.

Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease.

Journal: Neurobiology of disease

Published: September 07, 2023

Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates.

Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates.

Journal: Brain : a journal of neurology

Published: April 19, 2023

Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives.

Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives.

Journal: Biomedicines

Published: December 20, 2021

Adeno-Associated Viral Vectors as Versatile Tools for Parkinson's Research, Both for Disease Modeling Purposes and for Therapeutic Uses.

Adeno-Associated Viral Vectors as Versatile Tools for Parkinson's Research, Both for Disease Modeling Purposes and for Therapeutic Uses.

Journal: International journal of molecular sciences

Published: May 24, 2021

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques.

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques.

Journal: International journal of molecular sciences

Published: March 30, 2021

Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates.

Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates.

Journal: Brain structure & function

Published: March 27, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026